Rare Cancers Australia founder and CEO Richard Vines sat down for a discussion with BioPharmaDispatch. He challenged the early direction of the health technology assessment review and called on health minister Mark Butler to set clear expectations for the process while saying it cannot be credibly conducted behind closed doors.
Richard Vines: A better designed spreadsheet is not going to help anybody
February 22, 2023 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
Australian researcher awarded Gilead Sciences global grant to explore novel approach in breast cancer
July 18, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 17 July
July 17, 2025 - - Podcast -
Another day, another confusing response to the threat of US tariffs
July 17, 2025 - - Latest News -
NDIS keeps growing but signs emerge that reforms are starting to work
July 17, 2025 - - Latest News -
USTR launches new investigation, with minimal ambition on pharmaceuticals
July 17, 2025 - - Latest News -
New Zealand starting to benefit after lifting advertising prohibition
July 17, 2025 - - Latest News -
Mark Butler restates support for health technology assessment reform
July 16, 2025 - - Latest News